Supportive care and treatment of symptoms are the typical management options for ADP. During acute attacks, patients are often hospitalized and given medications for nausea/vomiting, rapid heartbeat, and hypertension while their fluid and electrolyte levels are monitored. Glucose supplementation and intravenous hematin are the mainstay of treatment for acute attacks. Avoiding physical and psychological stressors has been shown to limit the reoccurrence of attacks. Specific drugs have been identified that can trigger ADP attacks. Inducers of the CYP-450 enzymes are drugs that should be discontinued or avoided in patients with ADP. Drugs included in this category are anti-convulsants like phenytoin and carbamazepine, and other drugs like barbiturates, St. John's wort, and rifampin.
Aminolevulinic acid dehydratase deficiency porphyria
Harderoporphyria
Pseudoporphyria
Hepatoerythropoietic porphyria
Donath–Landsteiner hemolytic anemia
Erythropoietic porphyria
Hepatic porphyria
Erythropoietic protoporphyria